A Study of Belzutifan (MK-6482) and Metformin in Healthy Adult Participants (MK-6482-039)

Completed · Phase 1

Conditions studied: Healthy

In brief

The goal of this study is to learn how belzutifan (MK-6482) affects the levels of metformin in a healthy person's body over time. Researchers will study levels of metformin in the blood and urine in healthy volunteers after taking metformin alone (Period 1) and metformin with belzutifan (Period 2).

Key facts

Study ID
NCT07121959
Run by
Merck Sharp & Dohme LLC
People needed
14
Starts
2025-08-18
Expected to finish
2025-09-26
Last updated by the study team
2025-10-15

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.